The Pharmacy Times® Immunization Resource Center is a comprehensive resource for clinical news and expert insights on common immunizations, such as flu, zoster, and COVID-19 vaccines.
November 22nd 2024
When you’re unsure about answering a patient question, err on the side of caution and refer them to a pharmacist.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Disease
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Disease
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Disease, Pulmonology
View More
Preparatory Actions Pharmacies Should Take to Prepare to Immunize the Public Against COVID-19
December 22nd 2020Pharmacy Times® interviewed Michael Flannery, PharmD, of the University of Rochester Medical Center, on the process that the hospital pharmacy has developed for vaccinations following the arrival of the Pfizer and Moderna COVID-19 vaccines.
Watch
Pfizer, BioNTech Granted Authorization for COVID-19 Vaccine in the European Union
December 22nd 2020The announcement came hours after the companies disclosed that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion to authorize the vaccine.
Read More
Managing Concerns Around Vaccinating the Public With the COVID-19 Vaccines
December 22nd 2020Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the concerns he has regarding the COVID-19 vaccination process ahead.
Watch
European Medicines Committee Issues Positive Opinion for COVID-19 Vaccine From Pfizer, BioNTech
December 21st 2020The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.
Read More
The Work of the COVID-19 Vaccine Education and Equity Project to Support COVID-19 Immunization
December 19th 2020Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.
Watch
Vaccine Billing Coverage Options: Seasonal Influenza and Future COVID-19 Vaccines
December 16th 2020A thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.
Read More
2020 Vaccination Recommendations for Patients With Chronic Medical Conditions
November 27th 2020In the midst of the COVID-19 pandemic, it is important that individuals who are at higher risk for poor outcomes from infection with vaccine-preventable diseases remain up-to-date with their immunizations.
Read More
Increased Supply of Intranasal Flu Vaccine Available for This Flu Season
September 11th 2020Pharmacy Times® interviewed Fred Peruggia, the head of marketing for respiratory and biologics vaccines at AstraZeneca, on the company’s production and distribution of an intranasal flu vaccine for this flu season.
Watch